Document is current
Any future updates will be listed below
-
Authors
do Nascimento, Daniela Meirelles https://orcid.org/0000-0002-2894-8237
Machado, Karina Costa
Bock, Patrícia Martins
Saffi, Marco Aurélio Lumertz
Goldraich, Livia Adams
Silveira, Anderson Donelli
Clausell, Nadine
Schaan, Beatriz D.
-
Funding
Funding for this research was provided by:
Fundo de Incentivo à Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (170291)
Instituto de Avaliação de Tecnologia em Saúde (465518/2014-1)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Conselho Nacional de Desenvolvimento Científico e Tecnológico
- License Information
-
More Information
Article History
Received: 15 August 2019
Accepted: 12 April 2020
First Online: 25 April 2020
Ethics approval and consent to participate
: The study procedures were approved by the research ethics board from the Hospital de Clínicas de Porto Alegre on August 8, 2017 (protocol No. 20170291). The informed consent document includes the objectives of the study, a description of the testing procedures, explanation about interventions and its randomized allocation nature, the potential risks and benefits involved in the study, information on anonymized data sharing, and liabilities of the researcher staff. Once a subject decides to participate, a signed and personally dated informed consent is obtained from the subject before any trial-related procedure. The investigator charged of providing study clarifications and seeking the participant’s ethical consent must allow the subject sufficient time to decide whether or not to participate in the trial. A copy of the consent form is given to the participant.
: Not applicable.
: All authors have no competing interests to disclose.
